SP

Splice Bio

Barcelona, ES · 6 known investors

splice.bio ↗

SpliceBio develops genetic medicines using a proprietary protein splicing platform to treat diseases caused by mutations in large genes. The company is currently in clinical stages, with its lead program targeting Stargardt Disease.

Investors · 6

NO

Novartis Venture Fund✓ verifiedBasel · $5M – $25M

RO

Roche Venture Fund✓ verifiedBasel · $648K – $3.2M

SA

Sanofi Ventures✓ verifiedCambridge · $5M

YS

Ysios Capital✓ verifiedBarcelona · $5.4M – $21.6M

AS

Asabys Partners✓ verifiedMadrid

CR

Criteria Bio VenturesBarcelona